# Infliximab Biosimilar in Takayasu's Arteritis

> **NCT03192878** · — · UNKNOWN · sponsor: **Ospedale San Raffaele** · enrollment: 30 (estimated)

## Conditions studied

- Takayasu Arteritis

## Interventions

- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT03192878
- **Lead sponsor:** Ospedale San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-01
- **Primary completion:** 2019-02
- **Final completion:** 2019-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03192878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03192878, "Infliximab Biosimilar in Takayasu's Arteritis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03192878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*